Understanding the Complexities of Melanoma Immunobiology and a Review of Immunotherapeutic Checkpoint Inhibitors

Abstract

Melanoma immunotherapy has emerged as a promising treatment approach for advanced melanoma, a lethal form of skin cancer. Despite the remarkable clinical outcomes observed with immune checkpoint inhibitors, melanoma still poses significant therapeutic challenges. In this review, we discuss the immune landscape of melanoma, including the interactions between tumor cells and immune cells in the tumor microenvironment, according to the latest research studies. We also cover the immunobiology of melanoma and the mechanisms by which melanoma can evade immunosurveillance. Additionally, the review highlights emerging immunotherapeutic strategies that can overcome these mechanisms, including combination therapies and the use of novel agents that target immune checkpoints, their efficacy, and potential adverse effects. The goal of this timely review is to provide an up-to-date understanding of the complex interplay between melanoma and the immune system, and to identify new opportunities for developing effective melanoma immunotherapies.